WATCH: New Developments in Drugs to Reduce Infection, March 2016

Dr. Jennifer Taylor-Cousar shares new developments in drugs that fight infections in the lungs of people with cystic fibrosis.

| 1 min read
Christina-Roman
Christina Roman
Christina-Roman-Jennifer-TC-Featured-Rectangle

Welcome to the last installment in our video series highlighting the ways Cystic Fibrosis Foundation Therapeutics (CFFT) and industry are tackling cystic fibrosis from every angle. This week's topic explores new approaches to fighting infections that are in CFFT's drug development pipeline.

Watch the video below to hear Dr. Jennifer Taylor-Cousar describe why lung infections are a common problem for people with CF and what is being done to address the different types of infections that are problematic for people with CF.

If you haven't already, check out the previous posts on restoring CFTR functionreducing inflammation and restoring liquid to airway surfaces in the lungs.

To learn more about drugs that are in development, visit our drug development pipeline. Or if you would like to search for a clinical trial, visit the clinical trial search tool

Share this article
Topics
Research | Drug Pipeline | Cystic Fibrosis Foundation Therapeutics (CFFT)
Christina-Roman

As community engagement manager for the Cystic Fibrosis Foundation, Christina works to help embed the voice of the community into the work of the Foundation. Before joining the community partnerships team Christina worked on the clinical trials team for 3 years and at Colorado Children's Hospital for 2 years supporting the CF team. She holds a master's degree in public health from the University of Colorado. Originally from Estes Park, Colo., Christina now lives in Washington, D.C., with her husband.

Recent Community Posts
What To Do When “Most People Will Be Fine” And You Are Not “Most People”
Blog | 8 min read
Struggling to Process My Son’s Rare Mutations
Blog | 6 min read
More Than a Lung Disease
Blog | 5 min read

This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community, including but not limited to people with CF and their families, belong solely to the blog post author and do not represent those of the Cystic Fibrosis Foundation, unless explicitly stated. In addition, the site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.